Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,134.7
18.5 (0.59%)

 

  • STI Straits Times Index
    3,134.7
    18.5 (0.59%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.9
    8.7 (0.55%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,664.3
    160.3 (0.61%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,978.7
    -12.3 (-0.41%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,472.9
    265.7 (1.20%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,169.6
    11.4 (0.19%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,082.8
    14.7 (0.71%)
    Index delayed 20 minutes
  • XAO XAO
    6,843.2
    79.9 (1.18%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 990.1M
  • Value: 1,160.8M
  • Rise: 178
  • Fall: 130
  • Unch: 524

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.091+0.012
AIMS APAC Reit1.370-0.110
Spackman0.017+0.003
Thomson Medical0.060+0.002
Golden Agri-Res0.210-0.005
YZJ Shipbldg SGD0.970-
Genting Sing0.920-
Mapletree Log Tr1.700+0.030
Jiutian Chemical0.014+0.001
SingTel3.170-

World Indices

World Indices
Name Last Change
Nasdaq 8,148.7 +100.1
HSI 26,664.3 +160.3
HSCEI 10,532.2 +32.0
Jakarta 6,169.6 +11.4
Nikkei 225 22,472.9 +265.7
SSE Comp 2,978.7 -12.3
Shanghai A 3,120.6 -13.0
Shanghai B 270.1 +0.2
PSE Comp 0.0
KOSPI 2,082.8 +14.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SIENNA BIOPHARMACEUTICALS INC SIENNA BIOPHARMACEUTICALS
Updated on 15 Oct 2019 (End of trading day)
Last (USD): 0.194 Change: -0.028 High: 0.215 Remarks: -
Change (%): -12.75 Low: 0.170
Open 0.210 Yesterday's Close 0.222
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 3,057,709 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.37713 Trailing EPS (USD) e -1.96635 NAV (USD) b 0.8730
PE a - Trailing PE f - Price / NAV b 0.2219
Dividend (USD) d - Cash In Hand (USD) g 1.5979 Issued & Paid-up Shares c 30,907,500
Dividend Yield (%) d - Price / Cash In Hand g 0.121 Treasury Shares h 198,000
Beta - 75 Daysi 3.325 R-Squared - 75 Days(%)i 5.11 Market Cap (M) 5.987
Beta - 500 Daysi 0.199 R-Squared - 500 Days (%)i 0.07 Enterprise Value (M) -13.083
Piotroski F Score 0 Exchange Code SNNA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 192.31 Free Float (%) 70.0
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 04 Oct 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 09 Aug 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SIENNA BIOPHARMACEUTICALS INC NASDAQ 5.987 - - 0.2219 -
Industry Pharmaceuticals: Major NASDAQ 1,457.523 258.035 33.672 2.0907 0.011
Local Peer SANOFI SPON ADR ECH REP 1/2 ORD EUR2 LEVEL II NASDAQ 114,162.881 22.405 27.755 1.7789 2.521
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 5,382.741 7.647 8.361 1.0758 3.780
Local Peer ALLAKOS INC NASDAQ 3,387.367 - - 22.2636 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 4,755.529 - - -142.0655 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 2,521.781 - - 7.2485 -
Local Peer RA PHARMACEUTICALS INC NASDAQ 2,213.512 - - 12.7440 -
Local Peer AKCEA THERAPEUTICS INC NASDAQ 1,873.664 - - 5.0826 -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 1,686.670 - - 10.6022 -
Local Peer TRICIDA INC NASDAQ 1,627.400 - - 4.6920 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 1,300.550 - - 5.2460 -
Local Peer ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS NASDAQ 1,093.817 - - 2.9470 -
Local Peer GOSSAMER BIO INC NASDAQ 1,061.722 - - 2.4051 -
Other Local Peers ODONATE THERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), DOVA PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PETIQ INC (NASDAQ), PRINCIPIA BIOPHARMA INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), AKORN INC (NASDAQ), BEYONDSPRING INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), AC IMMUNE SA (NASDAQ), OBSEVA SA (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), PROVENTION BIO INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), FORTY SEVEN INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), GAMIDA CELL LTD (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), IMMUNIC INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), ASSERTIO THERAPEUTICS INC (NASDAQ), NOVAN INC (NASDAQ), EYENOVIA INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), ESSA PHARMA INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), TELIGENT INC NEW (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), ENTERA BIO LTD (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), GEMPHIRE THERAPEUTICS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 350,587.343 22.919 21.466 5.7677 2.688
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 219,123.846 17.336 19.193 4.2610 1.943
Global Peer MERCK & CO INC NYSE 217,734.715 35.006 23.257 7.8790 2.369
Global Peer PFIZER INC NYSE 201,883.325 18.103 15.960 3.3901 3.908
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 115,997.756 53.919 53.070 8.5620 2.993
Global Peer ABBVIE INC NYSE 110,146.760 19.471 26.931 -12.8586 5.303
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 105,436.597 21.825 18.398 22.9230 4.814
Global Peer ELI LILLY AND COMPANY NYSE 105,908.000 32.769 25.441 38.0890 2.246
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 97,728.523 15.984 17.019 12.0657 2.167
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 84,781.959 17.232 13.598 5.2827 3.084
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), WUXI APPTEC (HKEx), CHINARES PHARMA (HKEx), INNOVENT BIO-B (HKEx), CMS (HKEx), HENLIUS-B (HKEx), JUNSHI BIO-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINAGRANDPHARM (HKEx), CSTONE PHARMA-B (HKEx), ZYMEWORKS INC (NYSE), CANSINOBIO-B (HKEx), UNITED LAB (HKEx), HUA MEDICINE-B (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), FUSEN PHARM (HKEx), IGBB (Bursa), LANNETT CO INC (NYSE), DAWNRAYS PHARMA (HKEx), AFT PHARMACEUTICALS LTD (ASX), NC HEALTHCARE (HKEx), CHARMACY PHAR (HKEx), Merck Tbk. (IDX), Phapros Tbk. (IDX), AGEX THERAPEUTICS INC (NYSE American), MEDLAB CLINICAL LIMITED (ASX), KOTRA (Bursa), NEP INTERLONG (HKEx), NOVA (Bursa), PALLA PHARMA LTD (ASX), Hyphens Pharma (SGX), BIOHLDG (Bursa), ZOMEDICA PHARMACEUTICALS CORP (NYSE American), MMJ GROUP HOLDINGS LTD (ASX), NOXOPHARM LTD (ASX), CRESO PHARMA LTD (ASX), SINOLIFE UTD (HKEx), EXOPHARM LTD (ASX), RECCE PHARMACEUTICALS LTD (ASX), Star Pharm^ (SGX), FARMAFORCE LTD (ASX), RACE ONCOLOGY LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), SUDA PHARMACEUTICALS LTD (ASX), FIJI KAVA LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.076
-28.26 %
10 Days --0.054
-21.90 %
20 Days -+0.014
+7.61 %
Medium Term Return 3 Months --0.580
-74.97 %
6 Months --1.776
-90.17 %
1 Year --11.596
-98.36 %
Long Term Return 2 Years --21.356
-99.10 %
Annualised Return Annualised --
-90.52 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.100 - 12.970 Change From 1 Year Low +0.094 % Change From 1 Year Low (%) +93.70
Change From 1 Year High -12.776 % Change From 1 Year High (%) -98.51
2 Years Range 0.100 - 25.710 Change From 2 Years Low +0.094 % Change From 2 Years Low (%) +93.70
Change From 2 Years High -25.516 % Change From 2 Years High (%) -99.25
5 Years Range 0.100 - 29.250 Change From 5 Years Low +0.094 % Change From 5 Years Low (%) +93.70
Change From 5 Years High -29.056 % Change From 5 Years High (%) -99.34
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Oct 2019 0.210 0.215 0.170 0.194 3,057,709 -
14 Oct 2019 0.245 0.246 0.220 0.222 1,797,507 -
11 Oct 2019 0.260 0.270 0.240 0.250 2,650,488 -
10 Oct 2019 0.260 0.275 0.240 0.260 2,706,312 -
09 Oct 2019 0.298 0.298 0.250 0.270 2,899,173 -
08 Oct 2019 0.319 0.335 0.261 0.295 5,820,753 -
07 Oct 2019 0.290 0.360 0.286 0.301 18,936,610 -
04 Oct 2019 0.218 0.295 0.210 0.251 11,287,140 -
03 Oct 2019 0.240 0.240 0.193 0.219 5,465,138 -
02 Oct 2019 0.292 0.350 0.205 0.248 19,494,420 -
01 Oct 2019 0.190 0.375 0.190 0.298 58,345,130 -
30 Sep 2019 0.125 0.220 0.124 0.200 37,197,070 -
27 Sep 2019 0.115 0.120 0.106 0.115 1,449,454 -
26 Sep 2019 0.129 0.139 0.110 0.115 3,295,767 -
25 Sep 2019 0.118 0.150 0.100 0.121 11,381,760 -
24 Sep 2019 0.148 0.148 0.105 0.113 5,429,795 -
23 Sep 2019 0.167 0.167 0.141 0.145 3,798,891 -
20 Sep 2019 0.170 0.190 0.158 0.160 4,412,448 -
19 Sep 2019 0.175 0.184 0.156 0.167 3,928,632 -
18 Sep 2019 0.207 0.223 0.178 0.180 15,727,280 -
17 Sep 2019 0.377 0.380 0.152 0.178 18,673,260 -
16 Sep 2019 0.680 0.706 0.670 0.673 122,887 -
Summary
Current 2 Weeks
(02 Oct 2019 to 15 Oct 2019)
0.292 0.360 0.170 0.194 74,115,250 -
Previous 2 Weeks
(18 Sep 2019 to 01 Oct 2019)
0.207 0.360 0.170 0.299 144,966,227 -
4 Weeks from
(20 Aug 2019 to 17 Sep 2019)
0.700 0.711 0.170 0.178 20,421,108 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.